T he accumulation of cholesteryl esters (CEs) in macrophages (foam cells) is characteristic of the early stage of atherosclerotic lesions, 16 and this accumulated cholesterol is primarily derived from low-density lipoproteins (LDLs). 7 ' 8 However, because LDL in its native form cannot convert macrophages into foam cells, it remains unclear why LDL is atherogenic at the cellular level. Goldstein et al 9 proposed a possible mechanism for LDL-derived cholesterol influx into macrophages: The LDL receptor is either absent or is poorly expressed in macrophages, but macrophages do have scavenger receptors to take up and degrade chemically modified or cell-modified LDL. Through this scavenger-receptor pathway, macrophages take up large amounts of cholesterol, which are converted to foam cells. 10 On the other hand, the cholesterol removal system from macrophage foam cells also functions at cellular levels.
1112 High-density lipoprotein (HDL) is thought to play a major role on this cholesterol removal system. and possibly with modified LDL. Therefore, if this removal system functions efficiently, the accumulation of cholesterol would be less likely to occur. In other words, cholesterol accumulation in macrophages might occur as a result of a disturbance in the balance of the cholesterol influx-efflux system. To date, less attention has been directed to the effect of LDL on the HDLmediated cholesterol removal system. We explored the notion that elevated levels of LDL may block this removal system and accelerate cholesterol accumulation in macrophages. For lipoprotein samples, we used two species of apolipoprotein (apo) A-I-containing lipoproteins isolated by immunoaffinity: (1) lipoprotein containing apoA-I but no apoA-II (LpA-I) and lipoprotein containing apoA-I and apoA-II (LpA-I/A-II), and (2) a subtraction of conventional HDL isolated by ultracentrifugation (HDL,).
Methods

Materials
All chemicals used were obtained from commercial sources. [l, 2- 3 H]cholesterol ([ 3 H]FC, 47.5 Ci/mmol) and [4- in the Kumamoto University School of Medicine (each group included five men and five women 18 to 25 years of age; all had fasted overnight). Five independent pooled plasma samples were used for the following studies.
Lipoproteins
LpA-I and LpA-I/A-II were isolated from each fresh pooled plasma sample by a combination of anti-apoA-I and anti-apoA-II immunosorbent columns, as previously described. 1618 Briefly, fresh plasma was applied on an anti-apoA-I column, and after washing extensively with 0.01 mol/L tris(hydroxymethyl)aminomethane (Tris), 0.5 mol/L NaCl, and 1 mmol/L EDTA, pH 7.5 (buffer A), the column was eluted with 0.1 mol/L acetic acid and 1 mmol/L EDTA, pH 3.0. Each effluent was immediately adjusted to pH 7.4 with 1.0 mol/L Tris solution and dialyzed against 0.15 mol/L NaCl and 1 mmol/L EDTA, pH 7.4 (buffer B). Finally, the sample was concentrated in buffer B using an ultrafiltration cell (Amicon Corp, Danvers, Mass) equipped with a PM-10 membrane and was then applied on an anti-apoA-II column. The column was washed with buffer A to obtain LpA-I. The bound fraction was eluted from the column to obtain LpA-I/A-II. Both LpA-I and LpA-I/A-II were dialyzed and concentrated. In this procedure, >90% of lipids and apolipoproteins applied were recovered in the unbound and bound fractions. A combined sample (A-ILp) in which LpA-I and LpA-I/A-II were mixed at an equiprotein ratio was obtained. LDL (d, 1.019 to 1.063) and HDL3 (d, 1.125 to 1.21) were isolated from a portion of the fresh pooled plasma sample by sequential ultracentrifugation at 150 000g for 22 hours at 4°C 19 and dialyzed against buffer B. These lipoproteins were used immediately after isolation in the following experiments. Acetyl LDL and pHJFC-labeled acetyl LDL were prepared as described. 16 
Rat Macrophage Monolayers
All cell culture experiments were done at 37°C in humidified air containing 5% CO2-16 * 22 Peritoneal macrophages were harvested in PBS from nonstimulated male Wistar rats (170 to 200 g), centrifuged at 800g for 3 minutes, and suspended at 2 to 3 x 10 6 cells per milliliter in Dulbecco's modified Eagle's medium containing 3% bovine serum albumin (BSA), 100 U/mL penicillin, and 100 /xg/mL streptomycin (medium A). To each 22-mm plastic dish was added 1.0 mL of the cell suspension, and the preparation was incubated for 4 hours. Cell monolayers formed were washed three times with 1 mL PBS and used for cholesterol efflux experiments.
Cholesterol Efflux From Macrophage Foam Cells
Adhered macrophages were converted to foam cells by a 16-hour incubation with 100 p.g/mL of unlabeled or pHJFC-labeled acetyl LDL in medium A, as previously described.
1622 After a 6-hour equilibration, these foam cells were washed twice with 1.0 mL PBS containing 0.2% BSA and with PBS and subjected to efflux assays by incubating with 1.0 mL medium A containing 400 fig LpA-I, LpA-I/A-II, A-ILp (LpA-I + LpA-I/A-II), HDL,, and the combination of these lipoproteins and LDL (0 to 800 ^g). LDL (0 to 800 ^g/mL) was also incubated with foam cells. For control conditions, parallel incubations were performed without lipoproteins. At 24 hours after the onset of efflux experiments, the culture medium was removed to analyze the total radioactivity and esterification rate; the wells were then washed twice with 1.0 mL PBS containing 0.2% BSA and four times with PBS, and the cellular lipids were then extracted. Unless otherwise specified, the data derived from these efflux assays were the mean of quintuplicate runs in five separate experiments.
Lipid Extraction
FC and CEs were extracted directly from macrophage monolayers. 16 ' 22 Briefly, to each well was added 0.6 mL hexane/isopropanol (3:2 [vol/vol]), and the cells were incubated for 30 minutes at room temperature. The organic solvent was saved, and the cells were extracted again with 0.6 mL of the same solvent. The combined extracts were dried under nitrogen and dissolved in 120 /xL isopropanol. Aliquots were used for both radioactivity and the mass estimations described below. After lipid extraction, cells in each well were washed with 1.0 mL PBS and dissolved in 0.5 mL of 0.1 mol/L NaOH for 10 minutes at 37°C. The supernatant was saved, and the wells were again treated with 0.3 mL of 0.1 mol/L NaOH. The combined supernatant was used to determine cell protein concentrations.
Cellular Radioactivity
Aliquots (20 yL) of lipid extracts were spotted in duplicate on a thin-layer chromatography (TLC) plate (Merck) and developed in n-hexane/diethyl ether/acetic acid/methanol (85:20:1:1 [vol/vol/vol/vol]). Spots corresponding to FC and CEs were cut out from the plate, and the radioactivities were determined.
Mass Determination
The cellular mass of FC and CEs was quantified by a modification of the enzymatic/fluorometric method, 23 as described previously. 1622 Briefly, a remaining portion (20 pL) of the lipid extract was added to 0.4 mL of the enzyme mixture, and the preparation was incubated at 37°C for 1 hour (for FC) or for 2 hours (for total cholesterol), followed by the addition of 0.8 mL of 0.5 mol/L NaOH to halt the reaction. Fluorescence intensity was measured with excitation at 310 nm and emission at 407 nm. Values were quantified by comparison with standard curves obtained using cholesterol and cholesteryl oleate for FC and total cholesterol, respectively. The CE value was calculated by subtracting FC from total cholesterol. Standard curves were constructed for each set of experiments. 
FC Movement Between
Radioactivity Determination
To determine the radioactivity associated with LpA-I and LpA-I/A-II, LDL was precipitated from culture medium using phosphotungstate-MgCU. 24 - 25 Radioactivity associated with LDL was determined by the difference between the radioactivity before and after precipitation. The lipids in culture medium were extracted with methanol/chloroform (2:1 [vol/vol]). The extracts were dried under nitrogen flush and dissolved in 60 yxL isopropanol. Aliquots (20 /xL) of lipid extracts were spotted in duplicate on a TLC plate, and radioactivities of FC and CE were determined as described above.
Protein and Lipid Analysis
Lipid concentrations of lipoprotein samples and culture medium were analyzed using an autoanaryzer and enzymatic methods 1618 or by selective precipitation of LDL using phosphotungstate-MgC^. 2425 The protein content of lipoproteins was determined by the method of Lowry et al. 26 
Electrophoretic Analysis
Agarose gel electrophoresis was performed using a Pol-E Film system for lipoprotein (Ciba Corning, Medfield, Mass).
Statistical Evaluation
The Wilcoxon signed rank test and paired t test were used to evaluate the data.
Results
Effect of LDL on Macrophages and Foam Cells
When macrophages were incubated with 400 jig/mL LDL for 24 hours, cellular FC and CE mass were Macrophages were converted to foam cells by a 16-hour incubation with 100 jig/mL acetyl LDL. These foam cells and unloaded macrophage monolayers were incubated in medium A containing no lipoprotein (-LDL) or 400 /ig/mL LDL (+LDL) for 24 hours at 37 °C, respectively. After incubation, the cells were washed twice with 1.0 mL phosphate-buffered saline containing 0.2% bovine serum albumin and four times with phosphatebuffered saline; cellular lipids were then extracted. The cellular mass of FC and CE was determined by an enzymatic/fluorometric method and expressed as nanomoles per milligram cell protein as described in "Methods."
slightly increased (Table 1 ). This indicates that macrophages possess the LDL receptor but that the activity was not enough for foam cell formation. In contrast, when cholesterol-loaded macrophages (macrophage foam cells) were incubated with the same amount of LDL, the cellular cholesterol mass did not change (Table 1) . In both cases, after incubation the mobility of LDL on agarose gel electrophoresis did not change when compared with the LDL before incubation, and lipid composition was also unchanged (data not shown). Therefore, these results suggest three possibilities: (1) LDL has no effect on the cholesterol in foam cells. (2) The influx and efflux of FC molecules occurred at equal mass. (3) Although LDL was taken up via the LDL receptor, LDL could remove the same amount of cellular cholesterol, and as a result, the cellular cholesterol mass did not change. For clarification, we performed experiments using radiolabeled foam cells. When these cells were subjected to a 24-hour incubation with an increasing amount of LDL, a significant amount of radioactivity was recovered in the incubation medium ( Fig 1A) . Fifty percent to 70% of cellular pH]FC was reduced, yet the cellular pH]CE level did not change ( Fig 1A) . On the other hand, the cellular cholesterol mass, both of FC and CE, did not change (Fig IB) . Because net removal of intracellular FC leads to CE reduction, 411 ' 12 -16 the unchanged cellular CE mass and cellular [ 3 H]CE level suggested that intracellular FC removal and CE influx via the LDL receptor did not occur. The LDL receptor was suppressed in foam cells, and efflux of cellular FC was completely compensated for by the influx from LDL into the plasma membrane of foam cells (a one-for-one exchange reaction between plasma membrane FC and FC in LDL). As a result, LDL had no effect on the cellular cholesterol mass in foam cells. 3 When foam cells were subjected to a 24-hour incubation with 400 tig LpA-I, LpA-I/A-II, A-ILp, and HDL3, (Fig 2A and 2B; LDL, 0 fig). A significant difference was not observed in total radioactivities excreted into the incubation medium, thereby indicating that the efflux of cellular cholesterol was constant in all cases (Fig 3; LDL, 0 fig) . At mass levels, these lipoproteins similarly decreased the cellular CE mass, but only LpA-I and A-ILp significantly decreased the cellular FC mass. LpA-I/A-II and HDL3 had no apparent effect on the cellular FC mass (Fig 2C and 2D) . The intracellular FC removal leads to CE reduction; hence, our data indicate that LpA-I/A-II and HDL3 removed only the FC mass generated by CE hydrolysis. In other words, the influx of FC from LpA-I/A-II and HDL3 was smaller than the cellular FC efflux by the FC mass generated by CE hydrolysis. In case of LpA-I and A-ILp, the influx from these lipoproteins to foam cells was much less than that of LpA-I/A-II and HDL,.
Effect of LDL on Cholesterol Efflux From Foam Cells Mediated by ApoA-I-Containing Lipoproteins and HDL
When varying amounts of LDL were added to the incubation medium containing 400 /xg/mL LpA-I, LpA-I/A-II, A-ILp, or HDL3, total radioactivities recovered in incubation media did not change significantly (Fig 3) . Reduction of cellular [ 3 H]FC was also not affected in any case (Fig 2A) . In contrast, the reduction of cellular pH]CE by LpA-I, LpA-I/A-II, A-ILp, and HDL, was dose-dependently weakened by the addition of LDL (Fig 2B) . At mass levels, cellular FC mass-reducing capacities of LpA-I and A-ILp were similarly weakened by the addition of LDL (Fig 2C) . The cellular CE mass-reducing capacity of LpA-I, LpA-I/A-II, A-ILp, and HDL3 was weakened by the addition of LDL in a dose-dependent manner (Fig 2D) . Significant cellular CE reduction by these lipoproteins and cellular FC reduction by LpA-I and A-ILp were not observed when we added more than 400 /xg/mL LDL. These data, taken together, suggest that FC influx from the mixture of these lipoproteins and LDL into foam cells was increased when compared with apoA-I-containing lipoproteins or HDL, only.
Effect of LDL on Esterification of Cholesterol Excreted From Foam Cells
In a previous report, 16 we showed that both LpA-I and LpA-I/A-II possess esterification activity of FC by lecithinxholesterol acyltransferase (LCAT) and that the cholesterol-reducing capacity of LpA-I but not LpA-I/A-II is closely linked to this esterification activity. According to Fielding and Fielding, 27 the inhibition of LCAT results in an increase in the FC influx from lipoproteins to cells but has no effect on the corresponding FC efflux from the plasma membrane. This seems to be similar to the results given in the previous section. Therefore, we examined the effect of LDL on the esterification activity in LpA-I. LpA-I, LDL, and the combination of LpA-I and LDL were incubated in PBS without foam cells at 37°C for 24 hours. As shown in Table 2 , when LpA-I only was incubated, the CE mass increased, and the FC mass decreased. These data confirm that the esterification of FC by LCAT does occur in LpA-I. In the case of LDL only, neither the FC nor the CE mass changed. When the combination of LpA-I and LDL was incubated, the CE mass in the incubation medium increased, and the FC mass decreased. The increased CE mass and the decreased FC mass were similar to findings in the case of LpA-I only. These results, taken together, indicate that LDL had no effect on the esterification activity in LpA-I. We also studied the effect of LDL on the esterification of FC excreted from foam cells. When radiolabeled foam cells were incubated with LpA-I and LDL, esterification of FC excreted from foam cells was remarkably reduced by the addition of LDL (Fig 4) . This means that LCAT in 3 (HDL 3 Lipoproteins (1 mg protein) were incubated in 1.0 mL phosphate-buffered saline at 37 °C for 24 hours. For LpA-I + LDL, a mixture of LpA-I (1 mg) and LDL (1 mg) was incubated in 1.0 mL phosphate-buffered saline at 37 "C for 24 hours. After incubation, FC and CE concentrations of the samples were analyzed. Data are expressed as the difference before and after incubation.
FIG 3. Line graph shows the effect of low-density lipoprotein (LDL) on [ 3 H]'cholesterol efflux from foam cells mediated by lipoprotein (Lp) A-I, LpA-I/A-II, LpA-I+LpA-I/A-II (A-ILp), or high-density lipoprotein
'Moles of CE were calculated from the molecular weight of cholesteryl linoleate.
LpA-I preferentially esterifies the FC derived from LDL. To confirm this, 3 (Fig 5B) . Specific radioactivity was significantly higher in LpA-I than in LDL, thereby suggesting that the FC efflux from LpA-I was less than the FC influx from LDL (Table 3) . These results lead to the notion that there is a bidirectional FC movement between LDL and LpA-I, that there is a net FC movement from LDL to LpA-I, and that esterification of FC from LDL does occur. Similar results were obtained in the case of LpA-I/A-II (data not shown). To confirm these phenomena at mass levels, we determined the lipid compositions of LpA-I and LpA-I/A-II before and after incubation with LDL. The mixture of LpA-I or LpA-I/A-II and LDL was incubated in PBS for 24 hours at 37°C (1 mL of PBS containing 2 mg of each lipoprotein). LpA-I and LpA-I/A-II were also incubated without LDL in PBS. After incubation, LDL was precipitated, and the lipid composition of LpA-I and LpA-I/A-II was determined. The protein mass of LpA-I and LpA-I/A-II did not change by incubation with LDL. Data were compared with the lipid composition of these lipoproteins incubated at 4°C. As shown in Table 4 , in LpA-I only was FC decreased and CE increased by the action of LCAT. However, after incubation with LDL, there were no significant changes of total lipid mass and lipid composition in LpA-I. As shown in Table 2 , after incubation with LDL the total FC decreased and CE increased in the mixture of LpA-I and LDL. Thus, our observations are interpreted to mean that there is a net FC movement from LDL to LpA-I, that the displaced FC is esterified by LCAT in LpA-I, and that the CE formed is transferred to LDL, possibly by the action of cholesteryl ester transfer protein in LpA-I. 16 In LpA-I/A-II only, as shown in Table 4 , FC decreased and CE increased slightly by the action of LCAT. However, differing from LpA-I, total lipid mass increased significantly after the incubation with LDL. With respect to lipid composition, the FC content increased, but the CE content did not change at the mass level. This suggests that the LCAT activity in LpA-I/A-II is too low to esterif y all of the FC moved from LDL and that there is a net FC movement from LDL to LpA-I/A-II.
Movement of FC From Foam Cells to LpA-I or LDL
As shown in Fig 6A, The total radioactivity excreted into the medium did not change when LDL was added; however, distribution of the radioactivity markedly changed. After incubation with LpA-I and LDL, radioactivity recovered in the LDL increased as a function of the amount of LDL (Fig 6B) . Specific radioactivity of pH]FC in LpA-I was significantly higher than that in LDL at 30 minutes of incubation. However, the specific radioactivity in LDL then became significantly higher than that in LpA-I (Table 5 ). These results indicate that before 30 minutes of incubation, cellular cholesterol is preferentially moved to LpA-I and that a large amount of cellular cholesterol may be directly moved to LDL. In the case of LpA-I/A-II as shown in Table 5 , a phenomenon similar to that seen with LpA-I was observed. However, specific radioactivities in LpA-I/A-II were always higher than those in LDL throughout the incubation period.
Discussion
In our previous report, 16 we found that the interaction of LpA-I or LpA-I/A-II with macrophage foam cells induced a mass reduction in cholesterol from these cells, but related mechanisms differed. The cholesterol mass-reducing capacity of LpA-I but not of LpA-I/A-II was closely linked to the esterification activity by LCAT associated with LpA-I. On complete inactivation of LCAT, the cholesterol-reducing capacity of LpA-I was lost, yet that of LpA-I/A-II was not affected. In addition, we also described the relation between affinity-purified HDL (LpA-I and LpA-I/A-II) and HDL isolated by ultracentrifugation (HDL 2 and HDL,) 16 ; more than 70% of HDL 2 particles were LpA-I, and >70% of HDL, particles were LpA-I/A-II. The lack of cholesterol-reducing capacity of HDL 2 was attributed to the loss of LCAT during ultracentrifugation. The inhibition of LCAT associated with [ LpA-I or LpA-I/A-II (2 mg protein) was incubated with or without 2 mg LDL in 1.0 mL phosphate-buffered saline at 4°C or 37 °C for 24 hours. After incubation, LDL was precipitated using phosphotungstate-MgCl 2 . Lipid compositions of supernatants (LpA-I or LpA-I/A-II) were analyzed. Temperatures indicate the following: 4°C, before incubation; 37 °C, after incubation.
'Total lipid mass was expressed relative to the value before incubation.
LpA-I/A-II had no effect on the cholesterol-reducing capacity of LpA-I/A-II. This may explain why HDL3 is effective in cellular cholesterol reduction. Such being the case, in the following discussion we highlight only LpA-I and LpA-I/A-II. We found that LDL inhibits the cholesterol-reducing capacity of LpA-I and LpA-I/A-II in a dose-dependent manner. Two different mechanisms seem to be involved in this effect of LDL: (1) In the presence of LDL, LpA-I and LpA-I/A-II remove FC preferentially from LDL rather than from the plasma membrane of foam cells. ]FC-labeled acetyl LDL. After a 6-hour equilibration, cells were incubated with 400 /tg/mL LpA-I or LpA-I/A-II in 1.0 mL medium A containing 400 /xg/mL LDL. At several time points of incubation, aliquots of the mixture were taken, and LDL was precipitated from the mixture as described in "Methods." Radioactivity associated with LDL was calculated by the difference between the radioactivity before and after precipitation.
the LCAT in LpA-I. When foam cells were incubated with LpA-I in the presence of LDL, esterification of FC that originated from foam cells was remarkably inhibited (Fig 4) , yet LDL did not inhibit LCAT in LpA-I (Table  2) . In this study, FC movement from LDL to LpA-I and from LpA-I to LDL was rapid when compared with the movement from foam cells to LpA-I, and there was a net FC movement from LDL to LpA-I. As shown in Fig 5B, >80% of FC in LpA-I was moved to LDL within 30 minutes. However, once associated with LDL, approximately 20% of FC in LDL was transferred to LpA-I (the protein ratio of LDL to LpA-I was 1.0) (Fig 5A) . This means that the cellular FC moved to LpA-I is quickly moved to LDL before being esterified and that only a small amount of cellular FC returns to LpA-I. Therefore, as the amount of LDL increases in the incubation medium, LCAT on LpA-I catalyzes more FC derived from LDL than from foam cells. As a result, LCAT for FC from foam cells was selectively inhibited by the presence of LDL. Because the cholesterol-reducing capacity of LpA-I is lost by the inactivation of LCAT, 16 these results, taken together, can explain the blocking effect of LDL on the cholesterol-reducing capacity of LpA-I. Next, we turn attention to the inhibition effect of LDL on the cholesterol-reducing capacity of LpA-I/A-II, which depends little on LCAT. The cholesterol-reducing capacity of LpA-I/A-II may be related to particle size and to lipid composition. 16 ' 28 Although a change in particle size was not evident after incubation with LDL (data not shown), the lipid composition of LpA-I/A-II did change after incubation with LDL. FC increased and, as a result, the ratio of FC to phospholipid increased from 0.12 to 0.14 ( Table 4) . When we performed cholesterol efflux experiments using reisolated LpA-I/A-II after preincubation with LDL, the cholesterol-reducing capacity of LpA-I/A-II was significantly weakened (data not shown). Thus, it seems likely that these changes may affect the cholesterol-reducing capacity of LpA-I/A-II.
With respect to the distribution of cellular FC between LDL and HDL, Francone et al 29 reported that 82% of cell-derived cholesterol was in the HDL fraction before a 15-minute incubation and was then transferred to LDL or very-low-density lipoprotein. On the basis of the specific radioactivity of [ (Table 5) , similar to the findings of Francone et al, the SA in LpA-I or LpA-I/A-II was significantly higher than SA in LDL up to 30 minutes of incubation, but the increase of SA in LDL was greater than that in LpA-I or LpA-I/A-II. It may be that in addition to the FC transfer via LpA-I or LpA-I/A-II, a direct movement of cellular FC to LDL may occur in the case of coincubation with LpA-I or LpA-I/A-II and LDL. In the case of LpA-I/A-II, the SA in LpA-I/A-II was higher than in LDL throughout the incubation period. When we labeled LpA-I and LpA-I/A-II using [ 3 H]FC at 4°C, the SA in LpA-I/A-II was constantly 1.2 to 1.5 times higher than the SA in LpA-I. When labeling was carried out at 37°C, the SA in both lipoproteins was similar (data not shown). At 4°C, LCAT in LpA-I does not function, 16 and in the presence of LDL, esterification for cellular FC is inhibited. Thus, the decreased SA in LpA-I (decreased [ 3 H]FC movement from cell to LpA-I) may explain the difference between LpA-I and LpA-I/A-II. However, the total radioactivity recovered in LDL was much greater than that in LpA-I/A-II (the ratio of FC content in LDL to LpA-I or LpA-I/A-II was approximately 6.0 when the protein ratio was equal). Under such conditions, the efficient removal of cellular cholesterol from foam cells can be inhibited. At present, we think that both mechanisms described above might function with regard to the inhibitory effect of LDL.
The results obtained in the present study might weaken the concept that a specific interaction of apoA-I with the plasma membrane is a key step in net cholesterol removal from cells. . Although the interaction of apoA-I with the plasma membrane may be important, our present data strongly suggest that without a net FC mass efflux from the plasma membrane, CE mass reduction does not occur.
Recent studies of foam cell formation have focused on the recognition of modified LDL by scavenger receptors. On the basis of a substantial body of evidence, cholesterol that has accumulated in foam cells is assumed to be derived from oxidized LDL. 3233 However, there is no available evidence that elevated levels of LDL, a major risk factor for atherosclerosis, accelerate the synthesis of oxidized LDL. We propose that elevated levels of plasma LDL can accelerate foam cell formation by blocking net cholesterol removal from macrophage foam cells. In our unpublished data, the mean plasma apoB levels in normolipidemic Japanese adults was approximately 70 ing/ dL. This means that the protein ratio of LpA-I or LpA-I/A-II to LDL and A-ILp to LDL is approximately 1.0 and 2.0, respectively, in normolipidemic plasma. 17 In plasma, both LpA-I and LpA-I/A-II are present; therefore, approximately 50% of the cholesterol-reducing capacity of apoA-I-containing lipoproteins in plasma might be blocked by LDL.
Several studies show that the ratio of apoA-I-containing lipoproteins to LDL is higher in interstitial fluid than in plasma. 34 -37 If so, then the cholesterol removal system may function in the interstitial space. However, in hypercholesterolemic subjects, this system may be blocked by high concentrations of LDL in both the plasma and vascular wall. If our thesis is valid, the elevated levels of plasma LDL would become a risk factor for atherosclerosis at the cellular level.
